good news_老虎社区_美港股上老虎

2022-07-17

good news

InMode Shares Jump On Better Than Expected Q2 Interim Earnings<blockquote>InMode 股价因第二季度中期收益好于预期而上涨</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":686985205,"tweetId":"686985205","gmtCreate":1658037100409,"gmtModify":1704868825362,"author":{"id":3575270998964273,"idStr":"3575270998964273","authorId":3575270998964273,"authorIdStr":"3575270998964273","name":"细嫩老夫","avatar":"https://static.tigerbbs.com/c7648578e31733f3b3f8d683ebd256d5","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":6,"crmLevelSwitch":1,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","extraTitle":"","html":"<html><head></head><body><p>good news</p></body></html>","htmlText":"<html><head></head><body><p>good news</p></body></html>","text":"good news","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/686985205","repostId":2250925328,"repostType":2,"repost":{"id":"2250925328","kind":"highlight","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga Earnings","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1657635535,"share":"https://www.laohu8.com/m/news/2250925328?lang=zh_CN&edition=full","pubTime":"2022-07-12 22:18","market":"hk","language":"en","title":"InMode Shares Jump On Better Than Expected Q2 Interim Earnings<blockquote>InMode 股价因第二季度中期收益好于预期而上涨</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2250925328","media":"Benzinga Earnings","summary":"\n","content":"<p><html><body><ul> <li><strong>InMode Ltd </strong>(NASDAQ:INMD) expects Q2 sales of $113.0 million - $113.3 million, beating the consensus of $103.13 million.</li> <li>The company sees the adjusted EPS of $0.57 to $0.58, surpassing the consensus of $0.51, with a gross margin of 83% - 85%.</li> <li>For FY22, InMode forecasts sales of $425 million - $435 million, up from prior guidance of $415-$425 million.</li> <li>\"Our record results in the second quarter of 2022 are an indication of the strong demand for our proprietary technologies in the aesthetic surgical field. This positive momentum reinforces our confidence going into the second half of the year, and we are happy to increase our full-year guidance range from $415-$425 million to $425-$435 million,\" commented Moshe Mizrahy, InMode's CEO.</li> <li>InMode will release its second quarter of 2022 financial results on July 28.</li> <li><strong>Price Action:</strong> INMD shares are up 11.70% at $25.80 during the premarket session on the last check Tuesday.</li> </ul> </body></html></p><p><blockquote><html><body><ul><li><strong>英莫德有限公司</strong>（纳斯达克股票代码：INMD）预计第二季度销售额为 1.13 亿美元至 1.133 亿美元，超过市场普遍预期的 1.0313 亿美元。</li><li>该公司预计调整后每股收益为 0.57 美元至 0.58 美元，超过市场预期的 0.51 美元，毛利率为 83% - 85%。</li><li>InMode 预计 2022 财年销售额为 4.25 亿至 4.35 亿美元，高于之前指导的 4.15 亿至 4.25 亿美元。</li><li>“我们在 2022 年第二季度创纪录的业绩表明，美容外科领域对我们专有技术的强劲需求。这种积极的势头增强了我们对下半年的信心，我们很高兴将我们的全年指导范围从 415-4.25 亿美元增加到 4.25-4.35 亿美元，”InMode 首席执行官 Moshe Mizrahy 评论道。</li><li>InMode将于7月28日发布2022年第二季度财务业绩。</li><li><strong>价格行为：</strong>周二最后一次检查的盘前交易中，INMD 股价上涨 11.70%，至 25.80 美元。</li></ul></body></html></blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>InMode Shares Jump On Better Than Expected Q2 Interim Earnings<blockquote>InMode 股价因第二季度中期收益好于预期而上涨</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInMode Shares Jump On Better Than Expected Q2 Interim Earnings<blockquote>InMode 股价因第二季度中期收益好于预期而上涨</blockquote>\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time smaller\">2022-07-12 22:18</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<p><html><body><ul> <li><strong>InMode Ltd </strong>(NASDAQ:INMD) expects Q2 sales of $113.0 million - $113.3 million, beating the consensus of $103.13 million.</li> <li>The company sees the adjusted EPS of $0.57 to $0.58, surpassing the consensus of $0.51, with a gross margin of 83% - 85%.</li> <li>For FY22, InMode forecasts sales of $425 million - $435 million, up from prior guidance of $415-$425 million.</li> <li>\"Our record results in the second quarter of 2022 are an indication of the strong demand for our proprietary technologies in the aesthetic surgical field. This positive momentum reinforces our confidence going into the second half of the year, and we are happy to increase our full-year guidance range from $415-$425 million to $425-$435 million,\" commented Moshe Mizrahy, InMode's CEO.</li> <li>InMode will release its second quarter of 2022 financial results on July 28.</li> <li><strong>Price Action:</strong> INMD shares are up 11.70% at $25.80 during the premarket session on the last check Tuesday.</li> </ul> </body></html></p><p><blockquote><html><body><ul><li><strong>英莫德有限公司</strong>（纳斯达克股票代码：INMD）预计第二季度销售额为 1.13 亿美元至 1.133 亿美元，超过市场普遍预期的 1.0313 亿美元。</li><li>该公司预计调整后每股收益为 0.57 美元至 0.58 美元，超过市场预期的 0.51 美元，毛利率为 83% - 85%。</li><li>InMode 预计 2022 财年销售额为 4.25 亿至 4.35 亿美元，高于之前指导的 4.15 亿至 4.25 亿美元。</li><li>“我们在 2022 年第二季度创纪录的业绩表明，美容外科领域对我们专有技术的强劲需求。这种积极的势头增强了我们对下半年的信心，我们很高兴将我们的全年指导范围从 415-4.25 亿美元增加到 4.25-4.35 亿美元，”InMode 首席执行官 Moshe Mizrahy 评论道。</li><li>InMode将于7月28日发布2022年第二季度财务业绩。</li><li><strong>价格行为：</strong>周二最后一次检查的盘前交易中，INMD 股价上涨 11.70%，至 25.80 美元。</li></ul></body></html></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"INMD":"InMode Ltd.","QTWO":"Q2 Holdings Inc"},"source_url":"https://www.benzinga.com/news/earnings/22/07/28033608/inmode-shares-jump-on-better-than-expected-q2-interim-earnings","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2250925328","content_text":"InMode Ltd (NASDAQ:INMD) expects Q2 sales of $113.0 million - $113.3 million, beating the consensus of $103.13 million.\nThe company sees the adjusted EPS of $0.57 to $0.58, surpassing the consensus of $0.51, with a gross margin of 83% - 85%.\nFor FY22, InMode forecasts sales of $425 million - $435 million, up from prior guidance of $415-$425 million.\n\"Our record results in the second quarter of 2022 are an indication of the strong demand for our proprietary technologies in the aesthetic surgical field. This positive momentum reinforces our confidence going into the second half of the year, and we are happy to increase our full-year guidance range from $415-$425 million to $425-$435 million,\" commented Moshe Mizrahy, InMode's CEO.\nInMode will release its second quarter of 2022 financial results on July 28.\nPrice Action: INMD shares are up 11.70% at $25.80 during the premarket session on the last check Tuesday.","news_type":1,"symbols_score_info":{"INMD":0.9,"QTWO":1}},"isVote":1,"tweetType":1,"viewCount":5258,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":8,"subscribersOnly":false,"subscribersOnlyAccessible":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/686985205"}